One study carried out in Northwest Ethiopia noted social stigma or discrimination, missed HIV clinical visits, tuberculosis therapy, CD4 cell count < 500 cells/mm3, and being in the WHO-HIV clinical stage III at the time of ART initiation as predicting factors of low adherence to ART medications among their sample population. This evidence concerns the gene CD4 and tuberculosis.